ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Regional Groups: Why 15 Were Not Among Those Funded; Cancer Regional Studies Review Committee Chartered

July 2, 1982

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

March 21, 2003

Mihich Recommendation for Antigen Development In BRMP Summarized

December 14, 1979

NCI Offers Chlorozotocin

November 18, 1977